Last update 08 May 2025

Amitriptyline Oxalate

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms-
Target-
Action-
Mechanism-
Therapeutic Areas
Nervous System DiseasesUrogenital DiseasesOther Diseases
Active Indication-
Inactive Indication
Chronic pelvic pain syndromeProstatitis
Originator Organization
Shenyang Huatai Medication Research Co., Ltd.
Active Organization-
Inactive Organization
Shenyang Huatai Medication Research Co., Ltd.
License Organization-
Drug Highest PhasePendingPhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

5
Clinical Trials associated with Amitriptyline Oxalate
NCT05110144
/ RecruitingPhase 2IIT
A Randomized, Double-blind, Placebo-controlled, Dose-escalation Study Evaluating the Efficacy of Two Doses of Duloxetine & Amitriptyline in Subjects With Refractory Chronic Cough
NCT05120934
/ RecruitingPhase 2IIT
A Randomized, Double-blind, Placebo Controlled, Dose Escalation Pilot Study Evaluating the Efficacy of Two Doses of Duloxetine and Amitriptyline in Interstitial Lung Disease-related Cough
CTR20200406
/ CompletedPhase 2
草酸阿米替林片治疗慢性前列腺炎/慢性盆腔疼痛综合征有效性安全性随机双盲安慰剂对照多中心Ⅱa期临床试验
[Translation] A randomized, double-blind, placebo-controlled, multicenter phase IIa clinical trial on the efficacy and safety of amitriptyline oxalate tablets in the treatment of chronic prostatitis/chronic pelvic pain syndrome
100 Clinical Results associated with Amitriptyline Oxalate
Login to view more data
100 Translational Medicine associated with Amitriptyline Oxalate
Login to view more data
100 Patents (Medical) associated with Amitriptyline Oxalate
Login to view more data
100 Deals associated with Amitriptyline Oxalate
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Chronic pelvic pain syndromePhase 2
China
Shenyang Huatai Medication Research Co., Ltd.
22 Apr 2020
ProstatitisPhase 2
China
Shenyang Huatai Medication Research Co., Ltd.
22 Apr 2020
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
NCT03096444 (CTgov)
Phase 2
Pruritus
13
(Topical KeAmLi Combo)
ppjuedlggd(qnvxkfilti) = oiyxpfgfth wdbdlrqosz (wllcdqjnov, kpcrbkozje - wrkwougweb)
View more
-
02 Jul 2019
(Topical Ketamine)
ppjuedlggd(qnvxkfilti) = rxblhwngrb wdbdlrqosz (wllcdqjnov, fnrvyijnpo - lzvbgkyiih)
View more
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free